Indicator Gauge Icon Legend
Legend Colors
Red is bad, green is good, blue is not statistically different/neutral.
Compared to Distribution
the value is in the best half of communities.
the value is in the 2nd worst quarter of communities.
the value is in the worst quarter of communities.
Compared to Target
meets target; 
does not meet target.
Compared to a Single Value
lower than the comparison value;
higher than the comparison value;
not statistically different from comparison value.
Trend
non-significant change over time; 
significant change over time; 
no change over time.
Compared to Prior Value
higher than the previous measurement period;
lower than the previous measurement period;
no statistically different change from previous measurement period.
Significantly better than the overall value
Significantly worse than the overall value
No significant difference with the overall value
No data on significance available
Colon Cancer Screening: USPSTF Recommendation
This indicator is archived and is no longer being updated. Click to learn more
This indicator shows the percentage of adults who met the USPSTF recommendation of screening for colorectal cancer through FIT, sigmoidoscopy, colonoscopy, FIT-DNA, and CT colonography.
Why is this important?
According to the Centers for Disease Control and Prevention (CDC), colorectal cancer--cancer of the colon or rectum-- is one of the most commonly diagnosed cancers in the United States, and is the third leading cancer killer in the United States. The CDC estimates that if all adults aged 50 or older had regular screening tests for colon cancer, as many as 60% of the deaths from colorectal cancer could be prevented. Risks and benefits of using different screening methods, such as stool-based tests, sigmoidoscopies, and colonoscopies, vary. The US Preventive Service Task Forces recommends that screening begin at age 45 and continue until age 75; however, testing may need to begin earlier or be more frequent if colorectal cancer runs in the family, or if there is a previous diagnosis of inflammatory bowel disease. Speak with a doctor about when to begin screening and how often to be tested.
| Region | Source | Measurement Period | Percent | |
|---|---|---|---|---|
Data Source
- CDC - PLACES
Note: This source uses Zip Code Tabulation Areas (ZCTAs) for its Zip Code data. Learn more
Maintained By: Conduent Healthy Communities Institute (Methodology)
Filed under: Health / Cancer, Clinical Care